Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.

World journal of gastroenterology - 7 Nov 2016

Dothel Giovanni, Raschi Emanuel, Rimondini Roberto, De Ponti Fabrizio

Abstract excerpt

The past decade has witnessed an outstanding scientific production focused towards the possible clinical applications of mesenchymal stromal cells (MSCs) in autoimmune and chronic inflammatory diseases. This raised the need of novel standards to adequately address quality, efficacy and safety issues of this advanced therapy. The development of a streamlined regulation is currently hampered by the complexity of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrointestinal Diseases
Share to Government Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Policy

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Regeneration

Share to Regenerative Medicine

Share to Translational Research, Biomedical

Source

Open in PubMed Open full text

Identifiers

PMID: 27895395
DOI: 10.3748/wjg.v22.i41.9057
PMCID: PMC5107589

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.PMID 27895395Read ↗

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.Semantic proximity Read ↗

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.Semantic proximity Read ↗

Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.Semantic proximity Read ↗

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesSemantic proximity Read ↗

Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesenterySemantic proximity Read ↗

Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damageSemantic proximity Read ↗

Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated SteatohepatitisSemantic proximity Read ↗

Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?Semantic proximity Read ↗

The Use of Potent Populations of Expanded Fetal Human Placental Stromal Cells for the Treatment of Dextran-Sodium-Sulfate Induced Colitis in a Mouse ModelSemantic proximity Read ↗

Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative MedicineSemantic proximity Read ↗

Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.Semantic proximity Read ↗

The therapeutic potential of mesenchymal stem cells in intestinal diseases: from mechanisms to clinical translationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.